[go: up one dir, main page]

DE69527994D1 - Verwendung von antisense-sequenzen zur erhöhung der antwort auf gen-amplifizierung - Google Patents

Verwendung von antisense-sequenzen zur erhöhung der antwort auf gen-amplifizierung

Info

Publication number
DE69527994D1
DE69527994D1 DE69527994T DE69527994T DE69527994D1 DE 69527994 D1 DE69527994 D1 DE 69527994D1 DE 69527994 T DE69527994 T DE 69527994T DE 69527994 T DE69527994 T DE 69527994T DE 69527994 D1 DE69527994 D1 DE 69527994D1
Authority
DE
Germany
Prior art keywords
cell
gene
response
increase
gene sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527994T
Other languages
English (en)
Inventor
Yves Mory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Interpharm Laboratories Ltd
Original Assignee
Interpharm Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interpharm Laboratories Ltd filed Critical Interpharm Laboratories Ltd
Priority claimed from PCT/US1995/015098 external-priority patent/WO1997020055A1/en
Application granted granted Critical
Publication of DE69527994D1 publication Critical patent/DE69527994D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y105/00Oxidoreductases acting on the CH-NH group of donors (1.5)
    • C12Y105/01Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
    • C12Y105/01003Dihydrofolate reductase (1.5.1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • C12N2310/111Antisense spanning the whole gene, or a large part of it

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE69527994T 1995-11-27 1995-11-27 Verwendung von antisense-sequenzen zur erhöhung der antwort auf gen-amplifizierung Expired - Lifetime DE69527994D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/015098 WO1997020055A1 (en) 1995-11-07 1995-11-27 Use of anti-sense sequences to increase responsiveness to gene amplification

Publications (1)

Publication Number Publication Date
DE69527994D1 true DE69527994D1 (de) 2002-10-02

Family

ID=22250144

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527994T Expired - Lifetime DE69527994D1 (de) 1995-11-27 1995-11-27 Verwendung von antisense-sequenzen zur erhöhung der antwort auf gen-amplifizierung

Country Status (5)

Country Link
EP (1) EP0863990B1 (de)
AT (1) ATE222957T1 (de)
AU (1) AU718896B2 (de)
CA (1) CA2235962A1 (de)
DE (1) DE69527994D1 (de)

Also Published As

Publication number Publication date
AU718896B2 (en) 2000-04-20
ATE222957T1 (de) 2002-09-15
EP0863990A1 (de) 1998-09-16
EP0863990B1 (de) 2002-08-28
AU4240896A (en) 1997-06-19
CA2235962A1 (en) 1997-06-05

Similar Documents

Publication Publication Date Title
MX9606476A (es) Inhibicion citoplasmica de expresion de genes.
DK1068311T3 (da) Fremgangsmåder og midler til opnåelse af modificerede fænotyper
UA42675C2 (uk) Спосіб активації гена, що в нормі транскрипційно мовчить, з геному еукаріотичної клітинної лінії, спосіб модифікації характеристик експресії гена з геному еукаріотичної клітинної лінії, диференційована еукаріотична клітинна лінія (варіанти), днк-конструкт
EP0542929A4 (en) Glycogen biosynthetic enzymes in plants
WO1995034668B1 (en) The cytoplasmic inhibition of gene expression
ATE471373T1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
NZ514025A (en) Compositions and methods for the modification of gene transcription
EP0672160B8 (de) Exprimierungsaktivation und vervielfältigung von endogenem gen mit homologer rekombination
GB9712415D0 (en) Genetic control of flowering
ATE184649T1 (de) Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen
HUP0002578A2 (hu) Hímszövet-specifikus szabályzó régió és alkalmazására szolgáló eljárás
EA199900875A1 (ru) Растения с изменённым ростом
MX9800500A (es) Inhibicion de la expresion de genes.
MX9800499A (es) Inhibicion de la expresion de genes.
DK0665882T3 (da) DNA-forbindelser omfattende sekvenser kodende for mannuronan C-5-epimerase
AU7532998A (en) Recombinant construct for enhancement of gene expression in plants
EP2281892A3 (de) Verfahren zur Herstellung von Polypeptiden in atmungsdefizienten Trichoderma Zellen
Arnaud et al. Analysis of the SINE S1 Pol III promoter from Brassica; impact of methylation and influence of external sequences
ATE222957T1 (de) Verwendung von antisense-sequenzen zur erhöhung der antwort auf gen-amplifizierung
DE69515652D1 (de) Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung
PL354747A1 (en) Modified ubiquitin regulatory system
CA2487290A1 (en) Ehd1 gene promoting plant flowering and utilization thereof
CA2289907A1 (en) Eukaryotic and retroviral antisense initiator elements
CA2343652A1 (en) Plant promoters and plant terminators
CA1312298C (en) Modifying cell metabolism via extra-cellular nucleases

Legal Events

Date Code Title Description
8332 No legal effect for de